These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 9004054

  • 21. Concomitant use of mirtazapine and phenytoin: a drug-drug interaction study in healthy male subjects.
    Spaans E, van den Heuvel MW, Schnabel PG, Peeters PA, Chin-Kon-Sung UG, Colbers EP, Sitsen JM.
    Eur J Clin Pharmacol; 2002 Sep; 58(6):423-9. PubMed ID: 12242602
    [Abstract] [Full Text] [Related]

  • 22. Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin.
    He L, Wickremasingha P, Lee J, Tao B, Mendell-Harary J, Walker J, Wight D.
    Diabetes Res Clin Pract; 2014 Jun; 104(3):401-9. PubMed ID: 24721587
    [Abstract] [Full Text] [Related]

  • 23. Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration.
    Purkins L, Wood N, Ghahramani P, Love ER, Eve MD, Fielding A.
    Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):37-44. PubMed ID: 14616412
    [Abstract] [Full Text] [Related]

  • 24. Single- and multiple-dose pharmacokinetics of nefazodone in patients with hepatic cirrhosis.
    Barbhaiya RH, Shukla UA, Natarajan CS, Behr DA, Greene DS, Sainati SM.
    Clin Pharmacol Ther; 1995 Oct; 58(4):390-8. PubMed ID: 7586930
    [Abstract] [Full Text] [Related]

  • 25. Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy.
    Levy RH, Ragueneau-Majlessi I, Garnett WR, Schmerler M, Rosenfeld W, Shah J, Pan WJ.
    J Clin Pharmacol; 2004 Nov; 44(11):1230-4. PubMed ID: 15496640
    [Abstract] [Full Text] [Related]

  • 26. Lack of pharmacokinetic interaction between lansoprazole and intravenously administered phenytoin.
    Karol MD, Locke CS, Cavanaugh JH.
    J Clin Pharmacol; 1999 Dec; 39(12):1283-9. PubMed ID: 10586395
    [Abstract] [Full Text] [Related]

  • 27. Lack of pharmacokinetic drug interactions between tiagabine and carbamazepine or phenytoin.
    Gustavson LE, Cato A, Boellner SW, Cao GX, Qian JX, Guenther HJ, Sommerville KW.
    Am J Ther; 1998 Jan; 5(1):9-16. PubMed ID: 10099032
    [Abstract] [Full Text] [Related]

  • 28. Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphan.
    Barbhaiya RH, Buch AB, Greene DS.
    Br J Clin Pharmacol; 1996 Nov; 42(5):573-81. PubMed ID: 8951188
    [Abstract] [Full Text] [Related]

  • 29. Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function.
    Barbhaiya RH, Brady ME, Shukla UA, Greene DS.
    Eur J Clin Pharmacol; 1995 Nov; 49(3):229-35. PubMed ID: 8666000
    [Abstract] [Full Text] [Related]

  • 30. Coadministration of nefazodone and benzodiazepines: IV. A pharmacokinetic interaction study with lorazepam.
    Greene DS, Salazar DE, Dockens RC, Kroboth P, Barbhaiya RH.
    J Clin Psychopharmacol; 1995 Dec; 15(6):409-16. PubMed ID: 8748429
    [Abstract] [Full Text] [Related]

  • 31. Coadministration of nefazodone and desipramine: a pharmacokinetic interaction study.
    Khan AY, Preskorn SH, Horst WD.
    J Pak Med Assoc; 2007 May; 57(5):230-5. PubMed ID: 17571477
    [Abstract] [Full Text] [Related]

  • 32. Lack of pharmacokinetic interaction between zileuton and phenytoin in humans.
    Samara E, Cavanaugh JH, Mukherjee D, Granneman GR.
    Clin Pharmacokinet; 1995 May; 29 Suppl 2():84-91. PubMed ID: 8620675
    [Abstract] [Full Text] [Related]

  • 33. Nefazodone inhibits methylprednisolone disposition and enhances its adrenal-suppressant effect.
    Kotlyar M, Brewer ER, Golding M, Carson SW.
    J Clin Psychopharmacol; 2003 Dec; 23(6):652-6. PubMed ID: 14624194
    [Abstract] [Full Text] [Related]

  • 34. Pharmacokinetic and pharmacodynamic interactions of oral midazolam with ketoconazole, fluoxetine, fluvoxamine, and nefazodone.
    Lam YW, Alfaro CL, Ereshefsky L, Miller M.
    J Clin Pharmacol; 2003 Nov; 43(11):1274-82. PubMed ID: 14551182
    [Abstract] [Full Text] [Related]

  • 35. Pharmacokinetic interaction between ivabradine and phenytoin in healthy subjects.
    Vlase L, Popa A, Neag M, Muntean D, Leucuta SE.
    Clin Drug Investig; 2012 Aug 01; 32(8):533-8. PubMed ID: 22765768
    [Abstract] [Full Text] [Related]

  • 36. Lack of an effect of nefazodone on the pharmacokinetics and pharmacodynamics of theophylline during concurrent administration in patients with chronic obstructive pulmonary disease.
    Dockens RC, Rapoport D, Roberts D, Greene DS, Barbhaiya RH.
    Br J Clin Pharmacol; 1995 Dec 01; 40(6):598-601. PubMed ID: 8703669
    [Abstract] [Full Text] [Related]

  • 37. Atovaquone has no effect on the pharmacokinetics of phenytoin in healthy male volunteers.
    Davis JD, Dixon R, Khan AZ, Toon S, Rolan PE, Posner J.
    Br J Clin Pharmacol; 1996 Aug 01; 42(2):246-8. PubMed ID: 8864327
    [Abstract] [Full Text] [Related]

  • 38. Evaluation of pharmacokinetic interaction between bromfenac and phenytoin in healthy males.
    Gumbhir-Shah K, Cevallos WH, DeCleene SA, Korth-Bradley JM.
    J Clin Pharmacol; 1997 Feb 01; 37(2):160-8. PubMed ID: 9055143
    [Abstract] [Full Text] [Related]

  • 39. Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment.
    Barbhaiya RH, Shukla UA, Greene DS.
    Eur J Clin Pharmacol; 1995 Feb 01; 49(3):221-8. PubMed ID: 8665999
    [Abstract] [Full Text] [Related]

  • 40. Acute and subchronic effects of nefazodone and imipramine on highway driving, cognitive functions, and daytime sleepiness in healthy adult and elderly subjects.
    van Laar MW, van Willigenburg AP, Volkerts ER.
    J Clin Psychopharmacol; 1995 Feb 01; 15(1):30-40. PubMed ID: 7714226
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.